Stabilized p53 peptides and uses thereof

Details for Australian Patent Application No. 2008210434 (hide)

Owner Harvard University DANA-FARBER CANCER INSTITUTE, INC.

Inventors Walensky, Loren D.; Bernal, Federico; Verdine, Gregory L.

Agent Griffith Hack

Pub. Number AU-A-2008210434

PCT Pub. Number WO2008/095063

Priority 60/887,526 31.01.07 US

Filing date 31 January 2008

Wipo publication date 7 August 2008

International Classifications

C07K 7/54 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

20 August 2009 PCT application entered the National Phase

  PCT publication WO2008/095063 Priority application(s): WO2008/095063

3 September 2009 Amendment Made

  The nature of the amendment is: Amend the applicant name name to President & Fellows of Harvard College

8 October 2009 Amendment Made

  The nature of the amendment is: Amend applicant name From: DANA-FARBER CANCER INSTITUTE, INC.; President & Fellows of Harvard College to: DANA-FARBER CANCER INSTITUTE, INC.; President and Fellows of Harvard College

17 December 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name DANA-FARBER CANCER INSTITUTE, INC.; President and Fellows of Harvard College, Application No. 2008210434, under INID (72) correct the inventors to include co-inventor Korsmeyer, Stanley

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008210455-2-aminopyridine derivatives useful as kinase inhibitors

2008210428-Heat-stable carbonic anhydrases and their use